Executive Vice President, Global Business Development. @ (January 2024 - October 2024)
Senior Vice President, Global Business Development @ (March 2022 - January 2024)
Senior Director of Business Development @ (July 2021 - March 2022)
Account Director at Oracle (HSGBU) @ (April 2012 - July 2021)
Solutions Sales Executive @ (January 2010 - April 2012)
District Sales Manager @ (January 2000 - January 2009)
District Sales Manager @ Parke-Davis Pharmaceutical (January 1991 - January 2000)
John Pappadakis Education
Saint Joseph's University - Erivan K. Haub School of Business
MBA (Administrative Management)
1988-1990
King's College
BS BA BS HCM (Business Management and Health Care Management)
1984-1988
John Pappadakis Skills
Biotechnology
Business Development
C Level Management
C Suite
CTMS
Cardiology
Clinical Development
Clinical Trial Management System (CTMS)
Clinical Trials
Cloud Applications
Cloud Security
Coaching
Competitive Analysis
Contract Negotiation
Customer Relationship Management (CRM)
Data Management
Data Warehousing
Design Environment
Diabetes
Electronic Data Capture (EDC)
Integrations
Key Account Development
Key Account Relationship Building
Leadership
Life Sciences
Lifesciences
Management
Marketing
Pharmaceutical Industry
Planning Budgeting & Forecasting
Private Clouds
Product Launch
Safety Management Systems
Signal Detection
Software as a Service (SaaS)
Strategic Negotiations
Team Leadership
John Pappadakis Summary
John Pappadakis, based in Naples, FL, US, is currently a Chief Commercial Officer (CCO) at Clinical ink. John Pappadakis brings experience from previous roles at Clinical ink and Oracle. John Pappadakis holds a 1988 - 1990 MBA in Administrative Management @ Saint Joseph's University - Erivan K. Haub School of Business. With a robust skill set that includes Biotechnology, Business Development, C Level Management, C Suite, CTMS and more. John Pappadakis has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different John Pappadakis?
Find contact details for 700 million professionals.